Document Detail

Changes in cell autophagy and apoptosis during age-related left ventricular remodeling in mice and their potential mechanisms.
MedLine Citation:
PMID:  23201404     Owner:  NLM     Status:  Publisher    
Cardiac structures and functions change with advanced age, but the underlying mechanisms are not well understood. Autophagy and apoptosis play important roles in the process of cardiac remodeling. This study was designed to explore changes in cell autophagy and apoptosis during age-related left ventricular remodeling and to determine whether the mitogen-activated protein kinase (MAPK) pathway is an underlying mechanism. Eight 5-month-old (adult group) and eight 24-month-old male C57bl/6 mice (aged group) were studied. The heart mass index, left ventricular mass index and hydroxyproline content of both groups were compared. Western blotting was used to quantify the protein expression of microtubule-associated protein 1 light chain 3 (LC3), Beclin-1, caspase-3, B-cell leukemia-2 (Bcl-2) and MAPKs in the left ventricles of adult and aged mice. Our results showed that the heart mass index, left ventricular mass index and hydroxyproline content in the left ventricles of the aged mice were increased significantly compared with the adult mice, indicating that left ventricular remodeling occurs with aging. The expression of LC3 and Beclin-1 in the left ventricles of aged mice were decreased significantly compared to adult mice. Meanwhile, the level of myocardial caspase-3 in adult mice remained the same in aged mice, and the level of myocardial Bcl-2 increased significantly in aged mice. There were no differences in the expression level of myocardial extracellular signal-regulated kinase 1/2 (ERK1/2), activated/phospho-ERK1/2, c-Jun N-terminal kinase 1/2 (JNK1/2) and p38 between aged and adult mice. However, the expression of myocardial activated/phospho-JNK1/2 increased significantly in aged mice, while activated/phospho-p38 decreased significantly. These findings indicate that autophagy decreases without a concurrent change in apoptosis during age-related left ventricular remodeling in mice. The MAPK pathway may be involved in the regulation of age-related left ventricular remodeling by modulating autophagy.
Longyun Peng; Xiaodong Zhuang; Lizhen Liao; Xuyu He; Jiaxiang Li; Xuanlan Chen; Guihua Lu; Hong Ma; Xiuren Gao
Related Documents :
25105924 - Design, synthesis and biological evaluation of 17-arylmethylamine-17-demethoxygeldanamy...
23328524 - Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoi...
24975834 - Hepatoprotective effects of mimic of manganese superoxide dismutase against carbon tetr...
23726674 - Temporomandibular joint pain: a critical role for trpv4 in the trigeminal ganglion.
3704304 - Post-parturition and late lactation urine: long-term effects of exposure on mouse activ...
17696964 - Increased voluntary exercise in mice deficient for tumour necrosis factor-alpha and lym...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-29
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  -     ISSN:  1090-2104     ISO Abbreviation:  Biochem. Biophys. Res. Commun.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-12-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Department of Cardiology, First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Road II, Guangzhou, Guangdong 510080, China.. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stabilization of MAPO1 by specific binding with folliculin and AMP-activated protein kinase in O(6)-...
Next Document:  Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes.